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Background: Carbonic anhydrase VI (CA-VI) is produced by the salivary gland and is secreted into the saliva.
Although CA-VI is found in the epithelial cells of distal straight tubule of swine kidneys, the exact function of CA-VI
in the kidneys remains unclear.
Results: CA-VI was located in the epithelial cells of distal straight tubule of swine kidneys.
A full-length cDNA clone of CA-VI was generated from the swine parotid gland by reverse transcription polymerase
chain reaction, using degenerate primers designed based on conserved regions of the same locus in human and
bovine tissues.
The cDNA sequence was 1348 base pairs long and was predicted to encode a 317 amino acid polypeptide with a
putative signal peptide of 17 amino acids. The deduced amino acid sequence of mature CA-VI was most similar
(77.4%) to that of human CA-VI. CA-VI expression was confirmed in both normal and nephritic kidneys, as well as
parotid. As the primers used in this study spanned two exons, the influence of genomic DNA was not detected.
The expression of CA-VI was demonstrated in both normal and nephritic kidneys, and mRNA of CA-VI in the normal
kidneys which was the normalised to an endogenous β–actin was 0.098 ± 0.047, while it was significantly lower in
the diseased kidneys (0.012 ± 0.007). The level of CA-VI mRNA in normal kidneys was 19-fold lower than that of the
parotid gland (1.887).
Conclusions: The localisation of CA-VI indicates that it may play a specialised role in the kidney.
Keywords: Carbonic anhydrase VI, cDNA, Swine kidney, mRNA, RT-PCR, Kidney diseaseBackground
Carbonic anhydrase (CA; EC 4.2.1.1) is a well-cha-
racterised enzyme that catalyses the reversible hydration
of CO2 to form HCO3
− and protons according to the
following reaction: CO2 + H2O ↔ H2CO3 ↔ HCO3
− +
H+. The first reaction is catalysed by CA and the second
reaction occurs instantaneously. The mammalian α-CA
gene family includes at least 15 enzymatically active iso-
forms with different structural and catalytic properties. Six
of the active CA isozymes are cytosolic (CA-I, −II, −III,* Correspondence: nishida@azabu-u.ac.jp; ochiaih@azabu-u.ac.jp
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unless otherwise stated.−VII, −VIII, and -XIII), 4 are membrane-associated (CA-
IV, −IX, −XII, and -XIV), 2 are mitochondrial (CA-VA
and CA-VB), and 1 is secretory form (CA-VI), while 2
CA-related proteins (CA-X and XI) are inactive variants
[1-3]. The physiological function of carbonic anhydrase is
to maintain the acid–base balance in various tissues and
biological fluids [4].
CA-VI has been previously purified from the saliva
and parotid glands of sheep [5] humans [6], cattle [7],
pigs [8], and dogs [9]. The enzyme is localised in the ser-
ous acinar and demilune cells of the parotid and sub-
mandibular glands [7,10], from which it is secreted into
saliva. CA-VI may participate in the regulation of saliv-
ary pH and buffer capacity, and protect the mouth and
upper alimentary canal against excess acidity [11]. OnLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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unique oligosaccharide structures on bovine CA-VI might
have an antibacterial function. Karhumaa et al. [13] also
suggested that the glycoproteins on CA-VI confer multi-
functionality on the enzyme.
To date, human, bovine, mouse, canine, and equine
CA-VI cDNAs have been cloned successfully [14-18].
CA-VI was previously reported to be present in the par-
otid gland, saliva, bile, and serum of pigs [19]. However,
the exact physiological and clinical significance of swine
CA-VI has not been established. Here, we demonstrated
immunohistochemical localization of CA-VI in the swine
kidney and deduced the nucleotide sequence of swine
CA-VI. Furthermore, we demonstrate expression of CA-
VI in both normal and diseased kidneys of pigs. These
data provide an initial step toward exploring the physio-
logical and pathological roles of CA-VI.
Methods
Tissue samples
Samples from normal kidneys (n = 9), parotid gland (n = 1),
and diseased kidneys (n = 19) of domestic pigs were taken
from a slaughterhouse in Miyagi prefecture (Japan).
Macroscopically, diseased swine kidneys showed signs
of necrosis (n = 7), nephritis (n = 7), pyelectasis (n = 3),
and cystic kidney (n = 2).
All samples were obtained in accordance with the
guidelines of the Laboratory Animal Care Committee of
Azabu University, Japan, and programs accredited by the
Office of Laboratory Animal Welfare (OLAW) USA
(#A5393-01) were used.
The samples were immediately fixed in neutralised 10%
formalin and Bouin’s solution, dehydrated with a graded
series of alcohols, cleared with xylene, and then embed-
ded in paraffin wax blocks that were cut into 4-μm-
thick histological sections. To observe the morphologic
changes, renal tissue samples were stained with hematoxylin
and eosin. Microscopic inspection of diseased kidney
revealed predominantly renal tubule necrosis and stromal
cell permeation.
Immunohistochemical staining of CA-VI in kidney
Biopsies of pig kidneys were performed. The samples
were immediately fixed in neutralized 10% formalin and
Bouin’s solution, dehydrated with a graded series of alco-
hols, cleared with xylene and then embedded in paraffin
wax blocks that were cut into 4 μm-thick histological
sections.
Endogenous peroxidase activity was blocked in depar-
affinized and rehydrated sections using 0.3% H2O2 in
methanol, and immersion in normal goat serum (2% in
PBS) for 20 min blocked fragment crystallizable recep-
tors. Monospecific primary antisera (diluted 1:2000)
against swine CA-VI produced in our laboratory [8] wasused to detect the respective isozymes during a 1-h incu-
bation. Antibody binding was visualized using the Vec-
tastain Elite avidin-biotin-peroxidase complex kit (ABC-
POD reagent kit; Vector) and diaminobenzidine (DAB)
according to the manufacturer’s protocol.
The kidney sections were stained with hematoxylin,
dehydrated through a graded alcohol series, and mounted
on coverslips.
Samples were observed and photographed under a
light microscope.
cDNA sequence of pig CA-VI
Total RNA was isolated from the parotid gland of a
healthy pig by using RNA extraction solution (Isogen;
Nippon Gene, Japan). Degenerate primers used for the
amplification of a central region of swine CA-VI cDNA
were designed based on the conserved sequences in hu-
man [14] and bovine [15] cDNAs. Reverse transcription-
polymerase chain reaction (RT-PCR) amplification was
then performed using the SuperScript One-Step RT-PCR
system (Life Technologies, MS, USA), according to the
manufacturer’s instructions. The RT-PCR products were
verified to be single bands on agarose gel electrophoresis
and were then purified using Ultrafree-DA (Millipore,
MA, USA) and Microcon YM-100 (Millipore). The puri-
fied DNA was cloned into a pGEM-T Easy cloning vec-
tor (Promega, WI, USA) and sequenced using a Thermo
Sequenase Fluorescent Labeled Primer Cycle sequencing
kit (Amersham Biosciences, NJ, USA) and a DSQ2000L
DNA sequencer (Shimadzu, Japan). In order to minimise
PCR errors, sequences from several clones were ana-
lysed. The consensus nucleotide sequence showed a high
similarity of approximately 80% to bovine CA-VI cDNA
sequences. In order to amplify the 3′ and 5′ regions of
pig CA-VI cDNA, 3′- and 5′ -rapid amplification of
cDNA ends (3′- and 5′-RACE) methods were employed.
3′-RACE was performed as previously described [20]
and 5′-RACE was carried out using a SMART RACE
cDNA amplification kit (Clontech, CA, USA), according
to the manufacturer’s protocol.
Each RACE product was cloned into the pGEM-T
Easy vector and sequenced by employing an AmpliTaq
Dye Terminator Cycle Sequencing FS Ready Reaction kit
(Applied Biosystems, CA, USA) on a 373A DNA se-
quencer (Applied Biosystems).
RNA extraction from FFPE tissue
A total of 19 diseased and 9 healthy kidney samples in
formalin-fixed, paraffin-embedded (FFPE) were used in
this study. The 4 pieces of 10-μm-thick FFPE sections
were cut from each paraffin block and collected in a 1.5-
mL tube. A NucleoSpin FFPE RNA isolation kit for FFPE
Tissues (Takara, Kyoto, Japan) was then used according
to the manufacturer’s protocol. Briefly, 1 mL of xylene
Figure 1 Immunohistochemical localization of CA-VI in the
swine kidney. CA-VI was found in the epithelial cells of the distal
straight tubule of swine kidneys. Scale bar: 50 μm.
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tions to remove traces of paraffin. The tissues were
digested with proteinase K at 60°C for 3 h and treated
with DNase I. After washing, total RNA, including a
small miRNA fraction, was eluted with distilled water
and stored at −80°C until use.
cDNA synthesis and PCR evaluation of pig CA-VI
Reverse transcription was performed using a SuperScript
III First-Strand Synthesis System (Invitrogen, Carlsbad,
CA) according to the manufacturer protocol, and the
resulting cDNA was used as a template for RT-PCR. Pri-
mer set used was purchased from Takara (Kyoto, Japan).
Primer sequences for the CA-VI genes were following;
forward: 5′-AGAATGTCCACTGGTTTGTGCTTG-3′;
reverse: 5′-GGATGGTCTTGTTCTGGTCATTCA-3′.
The expected product size of the PCR using this primer
set is 102 bp. PCR reaction was performed using Takara
Ex Taq™ Hot Start version (Takara, Kyoto, Japan). Ampli-
fication was conducted using the following protocol: initial
denaturation phase at 95°C for 30 s, and then 40 cycles at
95°C for 15 s for denaturation, then at 60°C for 30 s for an-
nealing and extension step. PCR products were loaded in
3% agarose gel.
Real-time PCR evaluation of pig CA-VI
Real-time quantitative PCR was performed using a Ther-
mal Cycler Dice® Real Time System II (Takara). Samples
(final volume of 25 μL) were run in duplicate and con-
tained the following: X1 SYBR® Premix Ex Taq™ II
(Takara) 1 μL 10 mM of each primer and 2 μL cDNA
template. Amplification conditions were carried out as
manufacturer’s protocol. The primer set used in CA-VI
amplification was the same as described above. The
housekeeping gene β-actin was used as a reference gene
(forward: 5′-TCTGGCACCACACCTTCT-3′, reverse; 5′-
TGATCTGGGTCATCTTCTCAC-3′; DDBJ accession
number AY550069). The Real-Time RT-PCR results are
presented as the gene expression of the target gene (CA-
VI) relative to that of the housekeeping gene (β-actin),
and CA-VI gene expression levels are achieved using the
2-ΔΔCT method of quantification [21].
Statistical analysis
To compare differences in the relative levels of CA-VI
mRNA between normal and nephritic kidneys, statistical
analysis was carried out using an unpaired t-test. Values
of P < 0.01 were considered to be statistically significant.
Results
Immunohistochemical study
The results of immunohistochemical localization of CA-
VI in the kidneys of clinically normal pigs were shownin Figure 1. CA-VI was located in the epithelial cells of
distal straight tubule of swine kidneys.Nucleotide sequence of swine CA-VI cDNA
A 1348-bp nucleotide sequence corresponding to full-
length swine CA-VI cDNA was obtained (accession
number AB333806), consisting of a 951-bp open read-
ing frame encoding swine CA-VI of 317 amino acids
(Figure 2A). A typical polyadenylation signal was found
in the 3′ untranslated region. The deduced 317 amino
acids included a signal peptide (17 amino acids) typical
of most secreted proteins where the region was enrich-
ed with hydrophobic residues [22]; thus, the predicted
mature protein consisted of 300 amino acids. To deter-
mine the genomic structure, the UCSC genome browser
site (http://genome.ucsc.edu/) was used to align canine
genomic sequences and the cDNA sequence of CA-VI
(Figure 2B).
The amino acid sequence of the deduced swine mature
CA-VI was 3 residues shorter than that of canine CA-
VI, and 9 residues (in the carboxy-terminal region) lon-
ger than that of mouse and human CA-VI, respectively.
The sequence of swine CA-VI showed approximately
77.4% identity to human CA-VI (Figure 3). Two cysteine
residues (amino acid positions 25 and 207), which are
known to form intra-molecular disulphide bonds in
sheep CA-VI [23], are conserved, and 3 histidine resi-
dues (amino acid positions 94, 96, and 121) responsible
for zinc binding were also found. In addition, 2 potential
N-glycosylation sites (Asn-X-Thr/Ser) were detected; 1
of these (amino acid positions 239–241, Asn-Lys-Thr) is
known to be glycosylated in sheep CA-VI [23].
Figure 2 Nucleotide and deduced amino acid sequences of swine CA-VI cDNA. The DDBJ accession number is AB333806. The termination
codon is asterisked and the polyadenylation signal is boxed. The putative signal peptides consisting of 17 amino acid is underlined. Arrows
indicate the positions of introns (A). Alignment of the cDNA sequence with swine genome chromosome 1 predicts 8 exons of 70–447 base pairs.
Exon ■: intron▬(B).
Figure 3 Comparison of the amino acid sequences of mature CA-VI in pigs, dogs, humans, sheep, and cattle. Multiple sequence
alignments were performed using the Genetyx program (version 12). Asterisks and dots indicate identical residues and conservative substitution,
respectively. Cys residues are indicated by diamonds, and His residues, by triangles. These are likely to form an intra-molecular disulphide bond
and to bind to zinc, respectively. The potential glycosylation sites are indicated by circles.
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Figure 4 RT-PCR analysis of CA-VI expression from FFPE
samples. m; 100-bp ladder, 1; parotid, 2; normal kidney, 3;
nephritic kidney.
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Figure 4 shows the RT-PCR analysis of CA-VI expres-
sion from FFPE samples. CA-VI expression was con-
firmed in both normal and nephritic kidneys, as well as
parotid. As the primers used in this study spanned two
exons, the influence of genomic DNA was not detected.Figure 5 Comparison of CA-VI expression in normal or diseased
kidneys from FFPE samples as shown by quantitative RT-PCR.
CA-VI levels were normalised to an endogenous β-actin mRNA. The
values represent the mean ± SD. Asterisks indicate a significant
difference between the normal and diseased kidneys (P < 0.05,
unpaired t-test).The levels of CA-VI mRNA in the kidney
Expression levels of CA-VI mRNA were measured by
qRT-PCR in FFPE samples of normal and diseased kid-
neys (Figure 4). The relative level of CA-VI mRNA in the
normal kidneys was 0.098 ± 0.047, while it was significantly
lower in the diseased kidneys (0.012 ± 0.007; p= 2.71 × 10−8,
Figure 5). The level of CA-VI mRNA in normal kid-
neys was 19-fold lower than that of the parotid gland
(1.887).Discussion
Fernley et al., [24] reported that CA-VI was absent from
the sublingual salivary gland, kidney, lung, adrenal, brain,
skeletal muscle, liver, heart, pancreas, small intestine, and
cerebrospinal fluid of sheep. However, CA-VI was found
in the lung, skeletal muscle, liver, heart, and pancreas of
pigs by using ELISA [19]. In the present study, we show
for the first time that CA-VI is expressed in the epithelial
cells of distal straight tubule of swine kidneys.
The expression of bovine CA-VI mRNA has previously
been detected in the parotid gland, liver, and mammary
gland of cow [25,26]. Canine CA-VI mRNA signals were
strong in the major salivary glands and weaker in the
minor salivary glands and esophagus, and were absent in
the pancreas, liver, and almost all parts of the digestive
tract, except the esophagus [17]. In the horse, CA-VI
mRNA was detected in the digestive tract, salivary glands,
testis, thyroid gland, and liver, but not in nerve tissue,
skeletal muscle, spleen, or lymph node [18].
To our knowledge, there have been no previous stud-
ies on CA-VI mRNA expression in normal and diseased
kidneys. Although the levels of CA-VI mRNA were
lower in diseased kidneys, further studies are necessary
to determine whether CA-VI is a suitable biomarker for
kidney disorders.
In the kidney, cytosolic CA-II accounts for >95% of all
CA activity. In humans, rabbits, and bovine species,
most of the remaining ~ 5% of renal CA is membrane
associated and consists of CA-IV and CA-XII [27] CA-II
is expressed in the renal proximal tubule; thin descend-
ing limb; thick ascending limb; and intercalated cells of
the cortical collecting duct, outer medullary collecting
duct, and inner medullary collecting duct. Schwartz [28]
described that the function of CA-II in renal H+/HCO3
−
transport is perhaps best understood by examining CA-
II interactions with specific transporters.
Räisänen et al., [29] suggested that CA-III is an oxyra-
dical scavenger that protects cells from oxidative dam-
age. Using HK-2 cells, which represent an established
model for normal human proximal tubule cells, Gailly
et al. [30] reported that exposure to 1 mM H2O2 in-
duced a significant increase in CA-III mRNA expression.
This suggests that CA-III may be a multifunctional
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from oxidative damage.
Recently, Pertovaara et al. [31] reported that the levels
of anti-CA-VI antibody were significantly higher in pa-
tients with primary Sjogren’s syndrome (pSS). The
amount of antibody correlated significantly with urinary
pH, and inversely with serum sodium concentrations.
Anti-CA-VI antibody seems to be associated with renal
acidification capacity in patients with pSS. However, the
role of CA-VI autoantibodies in modulating urinary pH
in the kidney remained perplexing, since the presence of
CA-VI has never been demonstrated in the human kid-
neys. Pertovaara et al. [31] speculated that anti-CA-VI
antibodies might exhibit cross-reactivity with CA-XIII
expressed in the kidneys. However, the molecular weight
of CA-XIII is 30 kDa [2] and the subunit molecular
weight of swine CA-VI is 37 kDa [8]. Furthermore, the
amino acid sequence homology between human CA-VI
and CA-XIII is only 35%, which is also the degree of
homology between CA-VI and CA-II [2]. We feel it is
unlikely that cross-reactivity explains the results above.
In support of this, despite a 62% amino acid sequence
homology between equine CA-I and CA-II, sera raised
against each of these isoforms do not exhibit cross-
reactivity with the other [32]. These results indicate that
anti human CA-VI serum does not cross-react with both
human CA-XIII and CA-II.
The exact function of CA-VI in the kidneys remains un-
clear at this stage. However, based on our preliminary
data, additional studies should be conducted to determine
whether measuring the CA-VI concentration in the urine
of pigs with kidney disorders is of clinical utility.Conclusions
CA-VI was located in the epithelial cells of distal straight
tubule of swine kidneys.
The cDNA sequence was 1348 base pairs long and
was predicted to encode a 317 amino acid polypeptide
with a putative signal peptide of 17 amino acids. The de-
duced amino acid sequence of mature CA-VI was most
similar (77.4%) to that of human CA-VI. The expression
of CA-VI was demonstrated in both normal and neph-
ritic kidneys, and the relative levels of CA-VI mRNA in
the nephritic kidneys were significantly lower than in
normal kidneys. The level of CA-VI mRNA in normal
kidneys was 19-fold lower than that of the parotid gland.Abbreviations
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